首页> 美国卫生研究院文献>Immunology >Insufficient interleukin-12 signalling favours differentiation of human CD4+ and CD8+ T cells into GATA-3+ and GATA-3+ T-bet+ subsets in humanized mice
【2h】

Insufficient interleukin-12 signalling favours differentiation of human CD4+ and CD8+ T cells into GATA-3+ and GATA-3+ T-bet+ subsets in humanized mice

机译:白细胞介素12信号不足会促进人CD4 +和CD8 + T细胞在人源化小鼠中分化为GATA-3 +和GATA-3 + T-bet +亚型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Differentiation of CD4+ T cells into type 1 or type 2 subsets is mediated by the expression of the opposing lineage defining transcription factors T-bet and GATA-3. However, the existence of GATA-3+ T-bet+ CD4+ T cells in mice suggests functional plasticity of these subsets. Little is known about type 1 and type 2 plasticity of human T-cell subsets in vivo. Here, we show that in the xenogeneic environment of humanized mice, which lacks a functional immune-regulatory network, human CD4+ and, notably, CD8+ T cells preferentially differentiate into interleukin (IL)-4+ GATA-3+ and IL-4+ interferon-γ+ GATA-3+ T-bet+ subsets. Treatment with recombinant human IL-12 or expansion of IL-12-producing human dendritic cells in vivo reverted this phenotype and led to the down-regulation of GATA-3 expression. These changes also correlated with improved antiviral immune responses in humanized mice. In conclusion, our study shows the capacity of human CD4+ and CD8+ T cells for stable co-expression of GATA-3 and T-bet in humanized mice and reveals a critical role for IL-12 in regulating this phenotype.
机译:CD4 + T细胞向1型或2型亚群的分化是由定义转录因子T-bet和GATA-3的相反谱系的表达介导的。然而,小鼠中GATA-3 + T-bet + CD4 + T细胞的存在提示这些亚群的功能可塑性。关于人体内T细胞亚型的1型和2型可塑性知之甚少。在这里,我们显示在缺乏功能性免疫调节网络的人源化小鼠异种环境中,人CD4 + 尤其是CD8 + T细胞优先分化为白介素(IL)-4 + GATA-3 + 和IL-4 + 干扰素-γ + GATA- 3 + T-bet + 子集。重组人IL-12的治疗或体内产生IL-12的人树突状细胞的扩增恢复了该表型,并导致GATA-3表达的下调。这些变化还与人源化小鼠中抗病毒免疫应答的改善有关。总之,我们的研究显示了人CD4 + 和CD8 + T细胞在人源化小鼠中稳定共表达GATA-3和T-bet的能力,并揭示了IL-12在调节该表型中的关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号